Biofrontera Ag Stock EBITDA
Biofrontera AG fundamentals help investors to digest information that contributes to Biofrontera's financial success or failures. It also enables traders to predict the movement of Biofrontera Stock. The fundamental analysis module provides a way to measure Biofrontera's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofrontera stock.
Biofrontera |
Biofrontera AG Company EBITDA Analysis
Biofrontera's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Biofrontera EBITDA | (4.19 M) |
Most of Biofrontera's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biofrontera AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Biofrontera AG reported earnings before interest,tax, depreciation and amortization of (4.19 Million). This is 100.48% lower than that of the Healthcare sector and 104.18% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.11% higher than that of the company.
Biofrontera EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biofrontera's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biofrontera could also be used in its relative valuation, which is a method of valuing Biofrontera by comparing valuation metrics of similar companies.Biofrontera is currently under evaluation in ebitda category among related companies.
Biofrontera Fundamentals
| Return On Equity | -124.08 | |||
| Return On Asset | -10.51 | |||
| Profit Margin | (55.98) % | |||
| Operating Margin | (35.09) % | |||
| Current Valuation | 69.38 M | |||
| Shares Outstanding | 28.36 M | |||
| Shares Owned By Institutions | 3.09 % | |||
| Number Of Shares Shorted | 5.49 K | |||
| Price To Earning | (24.73) X | |||
| Price To Book | 3.51 X | |||
| Price To Sales | 2.87 X | |||
| Revenue | 27.99 M | |||
| Gross Profit | 26.81 M | |||
| EBITDA | (4.19 M) | |||
| Net Income | (15.67 M) | |||
| Cash And Equivalents | 33.7 M | |||
| Cash Per Share | 1.19 X | |||
| Total Debt | 24.24 M | |||
| Debt To Equity | 1.12 % | |||
| Current Ratio | 3.93 X | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | (7.22 M) | |||
| Short Ratio | 0.14 X | |||
| Earnings Per Share | (0.62) X | |||
| Number Of Employees | 149 | |||
| Beta | 1.57 | |||
| Market Capitalization | 80.19 M | |||
| Total Asset | 16.02 M | |||
| Retained Earnings | (164.76 M) | |||
| Working Capital | 9.53 M | |||
| Current Asset | 13.57 M | |||
| Current Liabilities | 4.04 M | |||
| Z Score | -11.2 |
Pair Trading with Biofrontera
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofrontera position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Biofrontera Stock
If you are still planning to invest in Biofrontera AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biofrontera's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |